Amgen
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$340.7M
Focus Areas
7
Top Stage
Phase 3
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Neumora Therapeutics | $340.7M |
| deCode Genetics | — |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Neumora Therapeutics | $340.7M |
| deCode Genetics | — |